2Gkialas I K,Papadopoulos G. New therapeutic approaches in the management of metastatic renal cell carcinoma[J]. J BUON,2009,14 (3):399-404.
3Fisher R,Gore M,Larkin J,et al.Current and future systemic treatments for renal cell carcinoma [J].Semin Cancer Biol,2012,13 (6):231-240.
4Janzen N K,Kim H L,Figlin R A,et al.Surveillance after radical or partial nephrectomy for localized renal cell carcinoma and management of recurrent disease [J].Urol Clin North Am,2003,30(4):843-852.
5Russo P, Synder M,Vickers A,et al.Cytoreductive nephr- ectomy and nephrectomy/complete metastasectomy for metastatic renal cancer [J].Scientific World Journal,2007, 7:768-778.
6Russo P.Surgical intervention in patients with metastatic renal cancer: current status of metastasectomy and cyto- reductive nephrectomy[J]. Nat Clin Pract Urol,2004,1 ( 1 ):26-30.
9KUME H,KAKUTANI S, Y YAMADA, et al. Prognostic fac tors for renal ceil carcinoma with bone metastasis: who are the long-term survivors? [J]. J Urol, 2011,185(5) :1611-1614.
10EISEN T, AHMAD T, FLAHERTY KT, et al. Sorafenib in advanced melanoma: a phase II randomised discontinuation trial analysis[J]. Br J Cancer,2006,95(5) :581.
